- Medical_Professionals
- Medical_students
- Nurses
High-Impact Cancer Research 2019
With so many new and promising strategies and recent developments, the opportunities to produce and enable high-impact cancer research are unprecedented. Recent advances continue to expand and reshape our views of the essential features of cancer. We are learning important new aspects of how cancers develop, how to find and diagnose cancers earlier, how to design and unleash powerful new anti-cancer therapies, and how to evaluate cancer risk and even prevent tumors from arising. These advances are delivering useful, productive changes that lead to better cancer outcomes.
In this special program, world leaders in cancer research share their insights and teach this changing science. Participants learn the new fundamentals of a wide spectrum of cancer science and the skills necessary to envision, design and lead cutting-edge cancer research projects that can contribute to these changes.
This program is designed to help participants make high-impact contributions that lead to better cancer outcomes. As a participant, you will:
Explore the most current understanding of the molecular and cellular basis of cancer development, detection, diagnosis, treatment and prevention
Learn innovative science from the innovators themselves
Hear about new cancer treatments from the individuals who developed the therapies and are testing them in ongoing clinical trials
Hone the skills necessary to identify and answer key questions needed to make your own future contributions
Customize your learning experience for your specific interests
Build an international network of colleagues and friends
This Harvard Medical School program is open to both new and seasoned researchers. The customized facets of this program enable you to tailor your learning experience to your specific research interests and career goals.
Julian Adams, PhD
Chairman
Gamida Cell
Chief Scientific Officer, President
Clal Biotechnology Industries
Joseph H. Antin, MD
Chief and Program Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Steve Arkinstall, PhD
Chief Scientific Officer
Kymab
Jon C. Aster, MD, PhD
Professor of Pathology
Harvard Medical School
Associate Pathologist
Brigham and Women's Hospital
Andrew H. Beck, MD, PhD
Assistant Professor of Pathology
Harvard Medical School
Director, Molecular Epidemiology Research Laboratory, Pathology
Beth Israel Deaconess Medical Center
USD
2018-11-01
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Harvard Medical School
25 Shattuck St.,
Boston,
Massachusetts,
United States
Submission Info
Office for External Education
4 Blackfan Circle
4th Floor
Boston, MA 02115
Office for External Education
4 Blackfan Circle
4th Floor
Boston, MA 02115